Aspirin alone may be sufficient to balance the risks of venous thromboembolism (VTE) and bleeding following total knee replacement surgery, according to a study published online in JAMA Surgery.

Recreational marijuana use is linked to an increase in stroke prevalence in the U.S. population, according to a study presented at the 11th World Stroke Congress in Montreal. Results of the study were released just two days after Canada legalized recreational cannabis nationwide.

Avinger announced on Oct. 18 its Pantheris SV atherectomy device has gained CE mark approval, allowing it to be sold commercially in Europe. The system extends the plaque-removing technique for peripheral artery disease to smaller vessels with diameters between 2 and 4 millimeters.

Patients who resume oral anticoagulation treatment following intracerebral hemorrhage (ICH) are almost twice as likely to achieve functional recovery, according to a study published Oct. 9 in Stroke.

The FDA has approved rivaroxaban to reduce the risk of major cardiovascular events including stroke, myocardial infarction and cardiovascular death for people with chronic peripheral or coronary artery disease (PAD/CAD).

Antiepileptic drugs, regardless of brand or type, increase risk of stroke in seniors diagnosed with Alzheimer’s disease, according to research published in the Journal of the American Heart Association.

Direct oral anticoagulants (DOACs) can cut the short-term risk of thromboembolic events in half for patients who have undergone cardioversion of atrial fibrillation (AFib), suggests a meta-analysis published in the Journal of the American College of Cardiology.

When cardiologists get involved in the treatment of patients with a history of cancer and newly diagnosed atrial fibrillation (AFib), those people see a subsequent 11 percent reduction in the risk of stroke, according to a new study in the Journal of the American College of Cardiology. But those visits occur less often for that subgroup of patients than in AFib patients without cancer.